| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 104,766 | 111,877 | 124,540 | 144,813 | | Cost of Revenue | 76,194 | 82,419 | 92,337 | 102,727 | | | Gross Profit | 28,572 | 29,458 | 32,203 | 42,086 | | | Operating Expenses | | Research Development | 1,508 | 1,494 | 1,567 | 1,429 | | Selling General and Administrative | 17,823 | 19,938 | 21,743 | 21,444 | | Non Recurring | 2,473 | 2,482 | 405 | 34,831 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,252 | 5,544 | 8,488 | (15,618) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (145) | (1,781) | 162 | 3,362 | | Earnings Before Interest And Taxes | (12,256) | 3,763 | 8,650 | (12,256) | | Interest Expense | (12,589) | 6,240 | 6,349 | 5,883 | | Income Before Tax | 333 | (2,477) | 2,301 | (18,139) | | Income Tax Expense | (315) | (711) | 883 | 2,604 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 648 | (1,766) | 1,418 | (20,743) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 648 | (1,766) | 1,418 | (20,743) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $648 | ($1,766) | $1,418 | ($20,743) |
|
0.02% Nasdaq 
Income Statement
